採用
At Veracyte, we offer exciting career opportunities for those interested in joining a pioneering team that is committed to transforming cancer care for patients across the globe. Working at Veracyte enables our employees to not only make a meaningful impact on the lives of patients, but to also learn and grow within a purpose driven environment. This is what we call the Veracyte way – it’s about how we work together, guided by our values, to give clinicians the insights they need to help patients make life-changing decisions.
Our Values:
-
We Seek A Better Way: We innovate boldly, learn from our setbacks, and are resilient in our pursuit to transform cancer care
-
We Make It Happen: We act with urgency, commit to quality, and bring fun to our hard work
-
We Are Stronger Together: We collaborate openly, seek to understand, and celebrate our wins
-
We Care Deeply: We embrace our differences, do the right thing, and encourage each other
The Position:
We’re seeking an accomplished, hands-on Senior Director of Accounting to lead and scale our global accounting function. This role is responsible for end‑to‑end accounting operations including payroll, accounts payable, accounts receivable, general accounting, consolidation, SEC reporting, and stock administration. As a senior leader within Finance, you will partner closely with executive leadership, FP&A, Legal, HR, and external auditors to ensure accurate financial reporting, strong internal controls, and scalable systems and processes. This is a highly visible role for someone who combines deep technical accounting expertise with a passion for process improvement and building high‑performing teams.
Responsibilities:
-
Provide strategic leadership and oversight for all core accounting functions, including payroll, accounts payable, accounts receivable, general ledger, and month‑end close.
-
Own the global close and consolidation process, ensuring timely, accurate, and compliant financial statements.
-
Lead all external financial reporting, including SEC filings (10‑K, 10‑Q, 8‑K), technical accounting memos, and coordination with external auditors.
-
Oversee stock administration and equity accounting, including ASC 718 compliance and collaboration with Legal, HR, and third‑party administrators.
-
Establish, maintain, and continuously improve internal controls, accounting policies, and procedures to support SOX compliance and audit readiness.
-
Drive systems and process improvements across accounting and payroll, leveraging technology to improve efficiency, accuracy, and scalability.
-
Partner with FP&A and business leaders to support budgeting, forecasting, and financial analysis with accurate and timely actuals.
-
Lead, mentor, and develop a high‑performing accounting team, fostering accountability, collaboration, and professional growth.
-
Serve as a trusted advisor to executive leadership on accounting, reporting, and compliance matters.
-
Manage relationships with external auditors, tax advisors, payroll providers, and other third‑party partners.
-
Proactively identify risks, opportunities, and improvements as the business grows and evolves
Who You Are:
Required Qualifications:
-
12+ years of progressive accounting experience, including leadership roles in public company or late‑stage private company environments.
-
Deep expertise in U.S. GAAP, SEC reporting, consolidation, and technical accounting.
-
Proven experience overseeing payroll, AP, AR, and general accounting at scale.
-
Strong understanding of equity and stock‑based compensation accounting.
-
Demonstrated success leading month‑end close and audit processes with accuracy and discipline.
-
Experience driving systems implementations and process improvements (ERP, payroll, close automation, or reporting tools).
-
Exceptional leadership, communication, and stakeholder management skills.
-
High degree of integrity, judgment, and attention to detail.
-
CPA required.
Preferred Qualifications:
-
Experience in biotech, life sciences, or other highly regulated industries.
-
Prior experience supporting a high‑growth or newly public company.
-
Background in SOX implementation or optimization.
-
Experience with global or multi‑entity accounting structures.
-
Passion for building scalable processes and developing strong teams
, or
For candidates based in our San Diego office, the salary is $220,500 - 250,000.
For candidates working remote (US), the salary or hourly range is $215,000 - 240,000.
The final salary offered to a successful candidate will be dependent on several factors that may include but are not limited to years of experience, skillset, geographic location, industry, education, etc. Base pay is one part of the Total Package that is provided to compensate and recognize employees for their work, and this role may be eligible for additional discretionary bonuses/incentives, and restricted stock units.
Pay range**$215,000—$250,000 USD**
What We Can Offer You
Veracyte is a growing company that offers significant career opportunities if you are curious, driven, patient-oriented and aspire to help us build a great company. We offer competitive compensation and benefits, and are committed to fostering an inclusive workforce, where diverse backgrounds are represented, engaged, and empowered to drive innovative ideas and decisions. We are thrilled to be recognized as a 2024 Certified™ Great Place to Work® in both the US and Israel - a testament to our dynamic, inclusive, and inspiring workplace where passion meets purpose.
About Veracyte
Veracyte (Nasdaq: VCYT) is a global diagnostics company whose vision is to transform cancer care for patients all over the world. We empower clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our Veracyte Diagnostics Platform delivers high-performing cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and a powerful evidence-generation engine, which ultimately drives durable reimbursement and guideline inclusion for our tests, along with new insights to support continued innovation and pipeline development. For more information, please visit www.veracyte.com or follow us on LinkedIn or X (Twitter).
Veracyte, Inc. is an Equal Opportunity Employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status or disability status. Veracyte participates in E-Verify in the United States. View our CCPA Disclosure Notice.
If you receive any suspicious alerts or communications through LinkedIn or other online job sites for any position at Veracyte, please exercise caution and promptly report any concerns to careers@veracyte.com
総閲覧数
0
応募クリック数
0
模擬応募者数
0
スクラップ
0
類似の求人

Manager – New Glenn Integrated Avionics Test
Blue Origin · Space Coast, FL

Vice President, Corporate Tax
BNY Mellon · New York, NY, United States

Head of Finance (Taco Bell Foundation)
Yum! Brands · Irvine, CA, United States, US

Accounting Manager, Alternative Investment Products
Fidelity · Smithfield, Rhode Island, USA

Vice President, Fund Accounting Manager
BNY Mellon · Lake Mary, FL, United States
Veracyteについて

Veracyte
PublicVeracyte is a genomic diagnostics company that develops molecular tests to help guide treatment decisions for patients with cancer and other diseases.
501-1,000
従業員数
South San Francisco
本社所在地
$1.2B
企業価値
レビュー
3.6
10件のレビュー
ワークライフバランス
3.2
報酬
3.8
企業文化
3.8
キャリア
2.5
経営陣
2.3
65%
友人に勧める
良い点
Supportive team and colleagues
Good benefits
Meaningful and innovative work
改善点
Limited career advancement and growth opportunities
Heavy workload and overwhelming work
Poor management and lack of direction
給与レンジ
0件のデータ
Mid/L4
Mid/L4 · Data Science Manager
0件のレポート
$497,003
年収総額
基本給
-
ストック
-
ボーナス
-
$422,452
$572,553
ニュース&話題
'40 Terabytes' of Evidence Involved in D4vd Murder Trial
HN
·
2d ago
·
1
·
1
Veracyte (VCYT) down 15.4% since last earnings report: Can it rebound? - MSN
MSN
News
·
3d ago
VCYT Veracyte delivers triple digit Q4 2025 EPS beat and 16 percent annual revenue growth despite mild stock dip. - Spin Off - Cổng thông tin điện tử tỉnh Tây Ninh
Cổng thông tin điện tử tỉnh Tây Ninh
News
·
3d ago
VCYT Veracyte delivers triple digit Q4 2025 EPS beat and 16 percent annual revenue growth despite mild stock dip. - EBITDA Margin - Xã Châu Thành
Xã Châu Thành
News
·
4d ago